An independent intelligence board aggregating credible research, preprints, clinical findings, biohacking experiments, and community discussions on therapeutic peptides, longevity science, and evidence-based anti-aging. Stories are scored for relevance, credibility, novelty, momentum, and practicality so the most important findings surface first.
Bowery Clinic, which offers doctor-supervised peptide treatments, is expanding its program and is highlighting selank, a synthetic peptide that some researchers have studied for stress, anxiety, and thinking support. The piece in USA Today talks about the clinic adding more information and access under physician oversight rather than over-the-counter or direct-to-consumer use. That’s the news: a clinic is promoting selank within a medical program it runs. Selank is a small man-made chain of amino acids designed to act like certain natural brain-signaling molecules. In plain terms, it’s a tiny lab-made messenger that researchers think can affect mood, stress responses, and maybe memory or attention. It’s not a pill you buy at a pharmacy with a long history of use like antidepressants or anti-anxiety drugs. Instead, it’s an experimental peptide that has been used in some countries and studied in labs and a limited number of people. What the research actually shows is limited and mixed. Some lab studies and small clinical reports—often from Russia and a handful of other places—suggest selank might reduce anxiety-like feelings and improve certain kinds of cognitive performance. But most of the evidence comes from small trials, animal studies, or short-term observations. There aren’t large, definitive clinical trials in diverse populations showing clear, lasting benefits. In short: early signals are interesting, but the scientific picture is far from settled. Why this matters for a regular person is practical: more clinics offering peptides means more people will hear about and potentially try them. For someone dealing with mild anxiety, stress, or brain fog who hasn’t responded to standard options, a physician-guided program could be a way to access something new under medical supervision. It also matters because it reflects a broader trend—more medical practices are offering experimental or off-label peptide therapies, so people need to know how much is proven and what isn’t. There are important caveats and risks. Peptides like selank are not widely approved by major regulators (for example, the FDA in the U.S.) for common psychiatric uses, and their long-term safety is not well established. Side effects in reports are usually mild but can vary, and mixing experimental peptides with other medications has unknown risks. People who are pregnant, breastfeeding, or have serious medical conditions should be especially cautious. Always ask for clear information about the evidence, possible side effects, and alternatives, and make sure any treatment is supervised by a clinician who will monitor you. Bottom line: Bowery Clinic is adding selank to its physician-managed offerings, but the science behind selank is still preliminary; if you’re curious, talk to a qualified doctor and weigh the uncertain benefits against the unknown risks.
Source: USA Today